Catatonia

CNS Spectrums

Volumn 21, Issue 4, 2016, Pages 341-348

  Walther, Sebastian ^a   Strik, Werner ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Brain imaging; catatonia; DSM 5; motor symptoms; schizophrenia; treatment

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; AMANTADINE; BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; CLOZAPINE; DIAZEPAM; DOPAMINE; GLUTAMIC ACID; LORAZEPAM; NEUROLEPTIC AGENT; NEUROTRANSMITTER; OXAZEPAM;

CATATONIA; CLINICAL FEATURE; CLINICAL RESEARCH; DSM-5; ELECTROCONVULSIVE THERAPY; FRONTAL CORTEX; HUMAN; ICD-10; MENTAL DISEASE; MOOD DISORDER; MOTOR CORTEX; NEUROIMAGING; NEUROPATHOLOGY; PARIETAL CORTEX; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; TREATMENT RESPONSE; CLASSIFICATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; INTERNATIONAL CLASSIFICATION OF DISEASES; PATHOPHYSIOLOGY; PSYCHOLOGY; SCHIZOPHRENIA;

BENZODIAZEPINES; CATATONIA; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ELECTROCONVULSIVE THERAPY; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MOOD DISORDERS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84973360866     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852916000274     Document Type: Review

References (65)

1. Kahlbaum K. Die Katatonie oder das Spannungsirresein. Eine klinische Form psychischer Krankheit. Vol Erstdruck Berlin: A. Hirschwald; 1874.
2. Fink M, Taylor MA. The catatonia syndrome: forgotten but not gone. Arch Gen Psychiatry. 2009; 66(11): 1173-1177.
3. Heckers S, Tandon R, Bustillo J. Catatonia in the DSM-shall we move or not? Schizophr Bull. 2010; 36(2): 205-207.
4. Ungvari GS, Caroff SN, Gerevich J. The catatonia conundrum: evidence of psychomotor phenomena as a symptom dimension in psychotic disorders. Schizophr Bull. 2010; 36(2): 231-238.
5. Walther S, Strik W. Motor symptoms and schizophrenia. Neuropsychobiology. 2012; 66(2): 77-92.
6. Stompe T, Ortwein-Swoboda G, Ritter K, Schanda H, Friedmann A. Are we witnessing the disappearance of catatonic schizophrenia? Compr Psychiatry. 2002; 43(3): 167-174.
7. Fink M, Shorter E, Taylor MA. Catatonia is not schizophrenia: Kraepelin's error and the need to recognize catatonia as an independent syndrome in medical nomenclature. Schizophr Bull. 2010; 36(2): 314-320.
8. Sienaert P, Dhossche DM, Vancampfort D, De Hert M, Gazdag G. A clinical review of the treatment of catatonia. Front Psychiatry. 2014; 5: 181.
9. Peralta V, Campos MS, de Jalon EG, Cuesta MJ. DSM-IV catatonia signs and criteria in first-episode, drug-naive, psychotic patients: psychometric validity and response to antipsychotic medication. Schizophr Res. 2010; 118(1-3): 168-175.
10. van der Heijden FM, Tuinier S, Arts NJ, Hoogendoorn ML, Kahn RS, Verhoeven WM. Catatonia: disappeared or under-diagnosed? Psychopathology. 2005; 38(1): 3-8.
11. Ungvari GS, Leung SK, Ng FS, Cheung HK, Leung T. Schizophrenia with prominent catatonic features ('catatonic schizophrenia'): I. Demographic and clinical correlates in the chronic phase. Prog Neuropsychopharmacol Biol Psychiatry. 2005; 29(1): 27-38.
12. Kruger S, Bagby RM, Hoffler J, Braunig P. Factor analysis of the catatonia rating scale and catatonic symptom distribution across four diagnostic groups. Compr Psychiatry. 2003; 44(6): 472-482.
13. Wing L, Shah A. Catatonia in autistic spectrum disorders. Br J Psychiatry. 2000; 176(4): 357-362.
14. Dhossche DM, Wachtel LE. Catatonia is hidden in plain sight among different pediatric disorders: a review article. Pediatr Neurol. 2010; 43(5): 307-315.
15. Tandon R, Heckers S, Bustillo J, et al. Catatonia in DSM-5. Schizophr Res. 2013; 150(1): 26-30.
16. Fink M. Rediscovering catatonia: the biography of a treatable syndrome. Acta Psychiatr Scand. 2013; 127(Suppl 441): 1-47.
17. Northoff G, Koch A, Wenke J, et al. Catatonia as a psychomotor syndrome: a rating scale and extrapyramidal motor symptoms. Mov Disord. 1999; 14(3): 404-416.
18. Lin CC, Huang TL. Lorazepam-diazepam protocol for catatonia in schizophrenia: a 21-case analysis. Compr Psychiatry. 2013; 54(8): 1210-1214.
19. Bush G, Petrides G, Francis A. Catatonia and other motor syndromes in a chronically hospitalized psychiatric population. Schizophr Res. 1997; 27(1): 83-92.
20. Ungvari GS, Chiu HF, Chow LY, Lau BS, Tang WK. Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study. Psychopharmacology (Berl). 1999; 142(4): 393-398.
21. Ungvari GS, Leung CM, Wong MK, Lau J. Benzodiazepines in the treatment of catatonic syndrome. Acta Psychiatr Scand. 1994; 89(4): 285-288.
22. Raffin M, Zugaj-Bensaou L, Bodeau N, et al. Treatment use in a prospective naturalistic cohort of children and adolescents with catatonia. Eur Child Adolesc Psychiatry. 2015; 24(4): 441-449.
23. Stuivenga M, Morrens M. Prevalence of the catatonic syndrome in an acute inpatient sample. Front Psychiatry. 2014; 5: 174.
24. Wilson JE, Niu K, Nicolson SE, Levine SZ, Heckers S. The diagnostic criteria and structure of catatonia. Schizophr Res. 2015; 164(1-3): 256-262.
25. Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia. I. Rating scale and standardized examination. Acta Psychiatr Scand. 1996; 93(2): 129-136.
26. Grover S, Chakrabarti S, Ghormode D, Agarwal M, Sharma A, Avasthi A. Catatonia in inpatients with psychiatric disorders: a comparison of schizophrenia and mood disorders. Psychiatry Res. 2015; 229(3): 919-925.
27. Peralta V, Cuesta MJ. Motor features in psychotic disorders. I. Factor structure and clinical correlates. Schizophr Res. 2001; 47(2-3): 107-116.
28. Kleinhaus K, Harlap S, Perrin MC, et al. Catatonic schizophrenia: a cohort prospective study. Schizophr Bull. 2012; 38(2): 331-337.
29. Peralta V, Cuesta MJ. Motor features in psychotic disorders. II. Development of diagnostic criteria for catatonia. Schizophr Res. 2001; 47(2-3): 117-126.
30. Krishna KR, Maniar RC, Harbishettar VS. A comparative study of "idiopathic catatonia" with catatonia in schizophrenia. Asian J Psychiatr. 2011; 4(2): 129-133.
31. Worku B, Fekadu A. Symptom profile and short term outcome of catatonia: an exploratory clinical study. BMC Psychiatry. 2015; 15: 164.
32. Peralta V, Campos MS, De Jalon EG, Cuesta MJ. Motor behavior abnormalities in drug-naive patients with schizophrenia spectrum disorders. Mov Disord. 2010; 25(8): 1068-1076.
33. Peralta V, Cuesta MJ. The effect of antipsychotic medication on neuromotor abnormalities in neuroleptic-naive nonaffective psychotic patients: a naturalistic study with haloperidol, risperidone, or olanzapine. Prim Care Companion J Clin Psychiatry. 2010; 12(2): PCC.09m00799.
34. Compton MT, Fantes F, Wan CR, Johnson S, Walker EF. Abnormal movements in first-episode, nonaffective psychosis: dyskinesias, stereotypies, and catatonic-like signs. Psychiatry Res. 2015; 226(1): 192-197.
35. Ungvari GS, Goggins W, Leung SK, Gerevich J. Schizophrenia with prominent catatonic features ('catatonic schizophrenia'). II. Factor analysis of the catatonic syndrome. Prog Neuropsychopharmacol Biol Psychiatry. 2007; 31(2): 462-468.
36. Consoli A, Raffin M, Laurent C, et al. Medical and developmental risk factors of catatonia in children and adolescents: a prospective case-control study. Schizophr Res. 2012; 137(1-3): 151-158.
37. Ghaziuddin N, Dhossche D, Marcotte K. Retrospective chart review of catatonia in child and adolescent psychiatric patients. Acta Psychiatr Scand. 2012; 125(1): 33-38.
38. Docx L, Morrens M, Bervoets C, et al. Parsing the components of the psychomotor syndrome in schizophrenia. Acta Psychiatr Scand. 2012; 126(4): 256-265.
39. Walther S, Vanbellingen T, Muri R, Strik W, Bohlhalter S. Impaired pantomime in schizophrenia: association with frontal lobe function. Cortex. 2013; 49(2): 520-527.
40. Walther S, Stegmayer K, Sulzbacher J, et al. Nonverbal social communication and gesture control in schizophrenia. Schizophr Bull. 2015; 41(2): 338-345.
41. Ungvari GS. Amineptine treatment of persistent catatonic symptoms in schizophrenia: a controlled study. Neuropsychopharmacol Hung. 2010; 12(4): 463-467.
42. Lauer M, Schirrmeister H, Gerhard A, et al. Disturbed neural circuits in a subtype of chronic catatonic schizophrenia demonstrated by F-18-FDG-PET and F-18-DOPA-PET. J Neural Transm. 2001; 108(6): 661-670.
43. Northoff G. Catatonia and neuroleptic malignant syndrome: psychopathology and pathophysiology. J Neural Transm. 2002; 109(12): 1453-1467.
44. Gouzoulis-Mayfrank E, Heekeren K, Neukirch A, et al. Psychological effects of (S)-ketamine and N, N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers. Pharmacopsychiatry. 2005; 38(6): 301-311.
45. Mohn AR, Gainetdinov RR, Caron MG, Koller BH. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell. 1999; 98(4): 427-436.
46. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011; 10(1): 63-74.
47. Steiner J, Walter M, Glanz W, et al. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. JAMA Psychiatry. 2013; 70(3): 271-278.
48. Northoff G, Steinke R, Czcervenka C, et al. Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding. J Neurol Neurosurg Psychiatry. 1999; 67(4): 445-450.
49. Pettingill P, Kramer HB, Coebergh JA, et al. Antibodies to GABAA receptor alpha1 and gamma2 subunits: clinical and serologic characterization. Neurology. 2015; 84(12): 1233-1241.
50. Walther S. Psychomotor symptoms of schizophrenia map on the cerebral motor circuit. Psychiatry Res. 2015; 233(3): 293-298.
51. Northoff G, Steinke R, Nagel DC, et al. Right lower prefrontoparietal cortical dysfunction in akinetic catatonia: a combined study of neuropsychology and regional cerebral blood flow. Psychol Med. 2000; 30(3): 583-596.
52. Galynker II, Weiss J, Ongseng F, Finestone H. ECT treatment and cerebral perfusion in catatonia. J Nucl Med. 1997; 38(2): 251-254.
53. Satoh K, Suzuki T, Narita M, et al. Regional cerebral blood flow in catatonic schizophrenia. Psychiatry Res. 1993; 50(4): 203-216.
54. Escobar R, Rios A, Montoya ID, et al. Clinical and cerebral blood flow changes in catatonic patients treated with ECT. J Psychosom Res. 2000; 49(6): 423-429.
55. Northoff G, Pfennig A, Krug M, et al. Delayed onset of late movement-related cortical potentials and abnormal response to lorazepam in catatonia. Schizophr Res. 2000; 44(3): 193-211.
56. Northoff G, Braus DF, Sartorius A, et al. Reduced activation and altered laterality in two neuroleptic-naive catatonic patients during a motor task in functional MRI. Psychol Med. 1999; 29(4): 997-1002.
57. Payoux P, Boulanouar K, Sarramon C, et al. Cortical motor activation in akinetic schizophrenic patients: a pilot functional MRI study. Mov Disord. 2004; 19(1): 83-90.
58. Scheuerecker J, Ufer S, Kapernick M, et al. Cerebral network deficits in post-acute catatonic schizophrenic patients measured by fMRI. J Psychiatr Res. 2009; 43(6): 607-614.
59. Northoff G, Kotter R, Baumgart F, et al. Orbitofrontal cortical dysfunction in akinetic catatonia: a functional magnetic resonance imaging study during negative emotional stimulation. Schizophr Bull. 2004; 30(2): 405-427.
60. Richter A, Grimm S, Northoff G. Lorazepam modulates orbitofrontal signal changes during emotional processing in catatonia. Hum Psychopharmacol. 2010; 25(1): 55-62.
61. Tsujino N, Nemoto T, Yamaguchi T, et al. Cerebral blood flow changes in very-late-onset schizophrenia-like psychosis with catatonia before and after successful treatment. Psychiatry Clin Neurosci. 2011; 65(6): 600-603.
62. De Tiege X, Bier JC, Massat I, et al. Regional cerebral glucose metabolism in akinetic catatonia and after remission. J Neurol Neurosurg Psychiatry. 2003; 74(7): 1003-1004.
63. Grignon S, Forget K, Durand M, Huppert T. Increased left prefrontal activation during staring/mutism episodes in a patient with resistant catatonic schizophrenia: a near infrared spectroscopy study. Cogn Behav Neurol. 2008; 21(1): 41-45.
64. Strik W, Wopfner A, Horn H, et al. The Bern psychopathology scale for the assessment of system-specific psychotic symptoms. Neuropsychobiology. 2010; 61(4): 197-209.
65. Stegmayer K, Horn H, Federspiel A, et al. Supplementary motor area (SMA) volume is associated with psychotic aberrant motor behaviour of patients with schizophrenia. Psychiatry Res. 2014; 223(1): 49-51.